{"id":9234,"date":"2020-04-28T13:21:05","date_gmt":"2020-04-28T11:21:05","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=9234"},"modified":"2024-11-07T14:27:26","modified_gmt":"2024-11-07T13:27:26","slug":"prof-dr-rolf-mueller","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-rolf-mueller\/","title":{"rendered":"Prof. Dr. Rolf M\u00fcller"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Rolf M\u00fcller participates in\u00a0RESIST research project C3.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>

As a part of the RESIST consortium, we will investigate molecular interactions within microbial communities relevant to human health and disease. A special focus will be put on the role of lung-based microbes and their influence on the emergence and progression of respiratory diseases. Previous studies by RESIST scientist Burkhard T\u00fcmmler identified a panel of bacteria that either positively or negatively affect the course of respiratory conditions.<\/p>\n

We will apply a set of microbiological, analytical, and bioinformatics technologies developed in our institute to shed light on the molecular mechanisms underlying the interaction between these isolates. In these studies, we will leverage on our experience with analysing the molecular physiology of myxobacterial communities. The generated knowledge will contribute to a better understanding of the observed correlation between composition of the lung microbiome and disease progression.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/i><\/span>Contact<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. M\u00fcller about his scientific work<\/h1><\/div>